AI BDR for Biotech & Life Sciences — Autonomous Outbound
Strides Agent helps biotech and life sciences companies reach VP Research, CROs, and procurement directors. AI-driven outreach built for long, technical sales cycles.
Biotech sales is highly technical and relationship-driven. Strides researches publications, pipeline milestones, and funding events to reach the right researcher or procurement director at the exact right moment.
By the Numbers
- 12–24mo — Complex sales cycles Strides manages
- 0 — SDR headcount required
- 6× — More pipeline conversations opened
- 48h — From funding event to first outreach sent
Built for Technical, Relationship-Driven Life Sciences Sales.
Research signal monitoring, technical persona outreach, and long-cycle nurturing for biotech and pharma pipeline.
Prospect Research
Finds, scores, and qualifies your ideal customers from 6 live data sources — hiring signals, funding rounds, intent data, and more.
Personalized Outreach
Writes and sends emails that reference the prospect's specific context. Not templates with merge fields — genuinely unique messages for every person.
AI Phone Calls
Real phone conversations with real objection handling. The AI books meetings on the call, detects voicemail in 2 seconds, and leaves a perfect message every time.
Inbound Handling
Responds to every inbound inquiry in under 60 seconds, qualifies them against your ICP, and books a meeting before your team even opens their laptop.
Autonomous Pipeline
Stranger to booked meeting without a single human touchpoint. The full outbound motion runs on its own, 24/7, across every timezone.
CRM Sync & Reporting
Every interaction logged to your CRM automatically. Calls transcribed, scored, and summarized. Full pipeline visibility without any manual data entry.
Why Biotech Sales Requires Smarter Signal Monitoring and Deeper Personalization
Biotech and life sciences sales is uniquely challenging because buyers are highly technical and extremely selective about who gets their attention. A VP of Research receiving a generic sales email about lab reagents or CRO services will delete it immediately. But an email that references their recent publication, their current pipeline phase, or their institution's recent grant award demonstrates relevance and gets a response.
The signals that matter in biotech are specific: Phase II/III trial initiations (indicating upcoming CRO needs), FDA approvals (triggering manufacturing scale-up), grant awards (creating equipment and service procurement budgets), partnership announcements (signaling new research directions), and leadership hires (VP Research appointments reset vendor relationships).
Strides monitors all of these signals from public sources — clinical trial registries, FDA databases, NIH grant databases, publication records, and news — and generates outreach that demonstrates genuine awareness of the prospect's specific situation. This level of research is what separates effective biotech outreach from spam.
Life sciences companies using Strides see the most impact in net-new vendor relationship development — particularly for CROs, lab equipment suppliers, and biotech SaaS companies that need to build pipeline with a highly specific set of decision-makers across hundreds of companies simultaneously.
What Customers Say
We were spending 3 hours a day on list building. Strides does it overnight while we sleep. We wake up to 200 verified, signal-qualified leads every morning.
Daniel Frey, Head of Sales at Paigo — 200 signal-qualified leads delivered every morning
Our previous tool sent the same email with the name swapped. Strides writes something different for every single person. Prospects actually respond saying they were impressed.
Jordan Lee, Director of Sales at Resend — Reply rate up 3.7× in the first 30 days
Related
- For Healthcare — Autonomous outbound for healthcare and clinical organizations.
- For Pharma — AI BDR for pharmaceutical companies and drug manufacturers.
- AI BDR — The complete autonomous BDR — from research to booked meeting.
Frequently Asked Questions
What data sources does Strides use for biotech prospect research?
ClinicalTrials.gov, FDA approval databases, NIH Reporter (grant awards), PubMed publication data, SEC filings for public biotechs, LinkedIn for personnel changes, Crunchbase for funding, and company press releases for partnerships and milestones.
Can Strides reach scientific decision-makers, not just business buyers?
Yes. Strides identifies and contacts VP Research, CSOs, lab directors, procurement managers, and principal investigators with messaging calibrated to their technical context and research focus area.
Does Strides work for CROs selling to pharma and biotech companies?
Yes. CROs are one of the primary use cases — identifying biotech companies initiating new studies, monitoring trial phase transitions, and reaching clinical operations and procurement teams at the right moment.
How does Strides handle the relationship-driven nature of biotech sales?
Strides prioritizes quality over quantity in biotech outreach. Rather than high-volume generic prospecting, it runs targeted, deeply researched outreach to a smaller set of highly qualified prospects — mimicking what a top-performing field sales rep would do manually, but at scale.
Can Strides support both large pharma and emerging biotech company targets?
Yes. Large pharma outreach targets procurement and vendor management departments. Emerging biotech outreach targets founders, CSOs, and operations leaders directly. Strides configures separate ICPs and messaging for each target tier.